| PACKAGING TYPE: | 10x10 Alu-alu (10 Strps In 1 Box) |
| COMPOSITION: | Repaglinide (0.5mg) + Voglibose (0.3mg) |
| FORMULATION: | Tablet |
| Description: | REPAMADE V 0.5/0.3 Tablet is a combination of Repaglinide 0.5 mg and Voglibose 0.3 mg. It is used for the management of type 2 diabetes mellitus, particularly for controlling postprandial (after-meal) blood glucose levels. Repaglinide stimulates insulin secretion from the pancreas, while Voglibose delays carbohydrate digestion and absorption, providing effective dual-action glycemic control. |
| Side Effects: | Common: Hypoglycemia (low blood sugar) Flatulence Abdominal discomfort Diarrhea Serious (Rare): Severe hypoglycemia Liver function abnormalities Allergic reactions (rash, swelling, difficulty breathing) |
| How to Use: | Take as prescribed by a healthcare professional Usually taken before meals Swallow the tablet with water Follow dietary and lifestyle recommendations Regular blood glucose monitoring is advised |
| Precaution: | Monitor blood sugar levels regularly Use with caution in patients with liver or kidney disorders Avoid alcohol as it may increase risk of hypoglycemia Inform your doctor about all medications being taken Not recommended during pregnancy or breastfeeding unless prescribed |
| Product Benefits: | Provides effective control of post-meal blood sugar spikes Dual mechanism enhances overall glycemic management Suitable for patients requiring lower repaglinide dose with higher voglibose strength Improves blood glucose stability throughout the day He |
Frequently Asked Questions
It is used for type 2 diabetes mellitus to control post-meal blood sugar levels.
It is suitable for patients needing mild insulin stimulation with stronger control of carbohydrate absorption.
Yes, under medical supervision with regular monitoring of blood glucose levels.










